Skip to main content

Framingham Heart Study Gutted

The iconic Framingham Heart Study, the longest-running cardiovascular study in the country, has been hit with a $4 million budget cut.

Written byChris Palmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, HEIKENWAELDER HUGOThe 65-year-old Framingham Heart Study, which has studied the causes and effects of cardiovascular disease, is faced with $4 million in budget cuts due to sequestration. The cuts mean 19 of the 90 study staff members will lose their jobs, the Huffington Post reported. In addition, the cuts could mean that the next round of testing, to be conducted over the next two to three years, could be threatened.

“You’re going to lose a major investment that we’ve been making over the last 65 years,” Karen Antman, dean of Boston University School of Medicine, which co-runs the Framingham Heart Study, told the Huffington Post. “This is an iconic trial that has more than proven its value from a public health point of view.”

In 1948, the Framingham study began with funding from the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH). Over the years, the cohort study has recruited more than 15,000 residents of Framingham, Mass., across three generations to help identify risk factors for diabetes, hypertension, hyperlipidemia, and other cardiovascular diseases. The Framingham study receives around $21 million in funding from the NIH annually, about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays